Elon Musk says ketamine can get you out of a ‘negative frame of mind’. What does the research say? 
Half our colleagues suffer pain and discomfort from periods. But they’re still a taboo subject at work 
Surgery won’t fix my chronic back pain, so what will? 
Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study 
Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances? 
Honey is said to help with hay fever symptoms – here’s what the research says about this claim 
What your sad desk sandwich says about your working habits 
How to look after your mental health while packing up Mum or Dad’s home 
Gut microbiome: meet Clostridium butyricum – the bacteria that helps keep us feeling our best 
Study links microplastics with human health problems – but there’s still a lot we don’t know 
Tapeworm larvae found in man’s brain – how did they get there? 
Snakebites: we thought we’d created a winning new antivenom but then it flopped. Why that turned out to be a good thing 
Good for your health and the environment: why we should be eating oily fish 
Gut microbiome: meet Roseburia intestinalis — the energy-producing bacterium that helps us fight against disease 
What if flat feet were…normal? Debunking a myth about injuries 
While having a definite cure for cancer is still in the works, the technological and medical advancements of today brought on some progress in that aspect. A report reveals a breakthrough made by scientists on the treatment of HER2-positive breast cancer.
CNN reports that a group of scientists were able to develop two new drugs for HER2-positive breast cancer treatment. A study in the New England Journal of Medicine revealed that scientists found that a drug called tucatinib, when combined with other drugs in the chemotherapy routine trastuzumab and capecitabine, can potentially improve survival within adults who are suffering from HER2-positive breast cancer, or the type of breast cancer that is high on a protein called HER2.
Another study in the same medical journal revealed that another drug conjugate, referred to as trastuzumab deruxtecan, also significantly reduced the tumor within HER2-positive breast cancer patients. Dr. Eric Winer of Harvard Medical School and the Dana-Farber Breast Cancer Institute expressed his happiness at the progress made upon the development of the drugs. “What’s so exciting is that we have developed multiple new drugs for HER2-positive breast cancer, we have new drugs for all subtypes of breast cancer, but the changes are most dramatic in the setting of HER2-positive breast cancer,” said Winer.
He added that because of the progress they made and will continue to make, breast cancer treatment can be configured to suit every kind of patient. “It is no longer one size fits all.”
Meanwhile, WebMD reveals that higher breast tissue density may increase a person’s chances of developing breast cancer. Many medical facilities in the United States are being urged to inform the women who undergo mammograms if they have high breast density tissue.
However, a new study that was conducted on this subject reveals that this may not be as helpful to women. While the objective of informing women if they have dense breast tissue is to be able to talk about their personal risk of developing breast cancer, later on, the study found that not many women actually understood what this would mean for them. Therefore, the researchers concluded that doctors or health care providers need to word their explanations properly, so it is understood and, at the same time, reduce other consequences like having anxiety regarding this.
